ChromaDex 주식 가격. CDXC - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

5.52

매수가

5.50

매도가

5.87

거래량

0.00 일간 변동폭 0.00

1.46 52주 범위 7.9738

market_cap

421.636M

전일 종가

5.52

개장가

최근 거래 시간

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

525,074

발행 주식

76,383,267

배당수익률

주가수익률

-85.45

주당순이익(EPS)

-0.06

매출

83.57M

순이익

-4.94M

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship in... ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors. 더 보기

섹터

Medicinal Chems,botanicl Pds

산업

Medicinal Chems,botanicl Pds

웹사이트

www.chromadex.com

본부

Dover, Delaware, USA

설립됨

ChromaDex Corporation is listed in the Medicinal Chems,botanicl Pds sector of the 나스닥 with ticker CDXC. The last closing price for ChromaDex was US$5.52. Over the last year, ChromaDex shares have traded in a share price range of US$ 1.46 to US$ 7.9738.

ChromaDex currently has 76,383,267 shares in issue. The market capitalisation of ChromaDex is US$421.64 million. ChromaDex has a price to earnings ratio (PE ratio) of -85.45.

ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

ChromaDex Corp. (NASDAQ: CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) with a focus on the science of healthy aging, today announced that it will participate in a...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category

ChromaDex Corp. (NASDAQ:CDXC) proudly announces its inclusion on the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best in Business Awards celebrate the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement

The gold standard in NAD+ supplementation, Niagen® is a key ingredient for supporting cellular health and promoting healthy aging in Longevity.Technology’s new supplement ChromaDex Corp. (NASDAQ:...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.01	-0.180831826401	5.53	5.8	5.45	267678	5.57974243	CS
4	0.29	5.54493307839	5.23	6.25	5.17	318555	5.70313146	CS
12	-1.44	-20.6896551724	6.96	7.9738	5.16	525074	6.4249302	CS
26	2.74	98.5611510791	2.78	7.9738	2.6986	789764	5.76206244	CS
52	4.06	278.082191781	1.46	7.9738	1.46	576171	4.88332401	CS
156	2.74	98.5611510791	2.78	7.9738	1.15	346140	3.52319523	CS
260	1.49	36.9727047146	4.03	23.66	1.15	546936	8.09332586	CS

CDXC - Frequently Asked Questions (FAQ)

What is the current ChromaDex share price?

The current share price of ChromaDex is US$ 5.52

How many ChromaDex shares are in issue?

ChromaDex has 76,383,267 shares in issue

What is the market cap of ChromaDex?

The market capitalisation of ChromaDex is USD 421.64M

What is the 1 year trading range for ChromaDex share price?

ChromaDex has traded in the range of US$ 1.46 to US$ 7.9738 during the past year

What is the PE ratio of ChromaDex?

The price to earnings ratio of ChromaDex is -85.45

What is the cash to sales ratio of ChromaDex?

The cash to sales ratio of ChromaDex is 5.05

What is the reporting currency for ChromaDex?

ChromaDex reports financial results in USD

What is the latest annual turnover for ChromaDex?

The latest annual turnover of ChromaDex is USD 83.57M

What is the latest annual profit for ChromaDex?

The latest annual profit of ChromaDex is USD -4.94M

What is the registered address of ChromaDex?

The registered address for ChromaDex is 838 WALKER ROAD, SUITE 21-2, DOVER, DELAWARE, 19904

What is the ChromaDex website address?

The website address for ChromaDex is www.chromadex.com

Which industry sector does ChromaDex operate in?

ChromaDex operates in the MEDICINAL CHEMS,BOTANICL PDS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
PNBKPatriot National Bancorp Inc	US$ 2.38 (64.14%)	8.06M
BSBKBogota Financial Corporation	US$ 12.60 (58.63%)	6
LCNBLCNB Corporation	US$ 24.49 (57.39%)	47
FUSBFirst US Bancshares Inc	US$ 19.99 (56.17%)	1
SPOKSpok Holdings Inc	US$ 24.99 (53.97%)	8
FENCFennec Pharmaceuticals Inc	US$ 3.00 (-54.89%)	107
OCSOculis Holding AG	US$ 10.01 (-54.81%)	1
PLRXPliant Therapeutics Inc	US$ 3.58 (-54.04%)	131.57k
ANIKAnika Therapeutics Inc	US$ 9.01 (-49.35%)	8
FXNCFirst National Corporation	US$ 15.01 (-43.36%)	27
MGOLMGO Global Inc	US$ 0.5854 (41.06%)	29.34M
CYNCYNGN Inc	US$ 0.0835 (38.70%)	25.38M
NIVFNewGenIvf Group Ltd	US$ 0.1521 (13.51%)	10.55M
STBXStarBox Group Holdings Ltd	US$ 0.5045 (51.73%)	9.47M
PNBKPatriot National Bancorp Inc	US$ 2.38 (64.14%)	8.06M